{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:20:20Z","timestamp":1762100420470},"reference-count":61,"publisher":"American Association for Cancer Research (AACR)","issue":"20","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2004,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>The E\u03bc-Myc transgenic mouse appears to be an accurate model of human Burkitt\u2019s lymphoma that bears MYC\/Immunoglobulin gene translocations. Id2, a negative regulator of basic helix-loop-helix transcription factors, has also been proposed as a Myc target gene that drives the proliferative response of Myc by binding to and overriding the checkpoint functions of the retinoblastoma tumor suppressor protein. Targeted deletion of Id2 in mice results in defects in B-cell development and prevents the development of peripheral lymphoid nodes. In precancerous B cells and lymphomas that arise in E\u03bc-Myc transgenic mice and in Burkitt\u2019s lymphomas, Id2 is overexpressed, suggesting that it plays a regulatory role in lymphoma development. Surprisingly, despite these connections, E\u03bc-Myc mice lacking Id2 succumb to lethal B-cell lymphoma at rates comparable with wild-type E\u03bc-Myc transgenics. Furthermore, precancerous splenic B cells lacking Id2 do not exhibit any significant defects in Myc-induced target gene transactivation and proliferation. However, due to their lack of secondary lymph nodes, E\u03bc-Myc mice lacking Id2 rather succumb to disseminated lymphoma with an associated leukemia, with pronounced infiltrates of the bone marrow and other major organs. Collectively these findings argue that targeting Id2 functions may be ineffective in preventing Myc-associated malignancies.<\/jats:p>","DOI":"10.1158\/0008-5472.can-04-2133","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T22:43:26Z","timestamp":1127256206000},"page":"7296-7301","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Id2 Is Dispensable for Myc-Induced Lymphomagenesis"],"prefix":"10.1158","volume":"64","author":[{"given":"Jonas A.","family":"Nilsson","sequence":"first","affiliation":[{"name":"1Department of Biochemistry and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa M.","family":"Nilsson","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrich","family":"Keller","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and the"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshifumi","family":"Yokota","sequence":"additional","affiliation":[{"name":"3Department of Molecular Genetics, School of Medicine, University of Fukui, Fukui, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelli","family":"Boyd","sequence":"additional","affiliation":[{"name":"2Animal Resource Center, St. Jude Children\u2019s Research Hospital, Memphis, Tennessee, and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John L.","family":"Cleveland","sequence":"additional","affiliation":[{"name":"1Department of Biochemistry and the"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2004,10,15]]},"reference":[{"key":"2022061620150918200_B1","doi-asserted-by":"crossref","unstructured":"Hermeking H The MYC oncogene as a cancer drug target. Curr Cancer Drug Targets\u20082003; 3: 163-75.","DOI":"10.2174\/1568009033481949"},{"key":"2022061620150918200_B2","doi-asserted-by":"crossref","unstructured":"de Alboran IM, O\u2019Hagan RC, Gartner F, et al Analysis of C-MYC function in normal cells via conditional gene-targeted mutation. Immunity\u20082001; 14: 45-55.","DOI":"10.1016\/S1074-7613(01)00088-7"},{"key":"2022061620150918200_B3","doi-asserted-by":"crossref","unstructured":"Cavalieri F, Goldfarb M Growth factor-deprived BALB\/c 3T3 murine fibroblasts can enter the S phase after induction of c-myc gene expression. Mol Cell Biol\u20081987; 7: 3554-60.","DOI":"10.1128\/mcb.7.10.3554-3560.1987"},{"key":"2022061620150918200_B4","doi-asserted-by":"crossref","unstructured":"Pelengaris S, Littlewood T, Khan M, Elia G, Evan G Reversible activation of c-Myc in skin: induction of a complex neoplastic phenotype by a single oncogenic lesion. Mol Cell\u20081999; 3: 565-77.","DOI":"10.1016\/S1097-2765(00)80350-0"},{"key":"2022061620150918200_B5","doi-asserted-by":"crossref","unstructured":"Baudino TA, McKay C, Pendeville-Samain H, et al c-Myc is essential for vasculogenesis and angiogenesis during development and tumor progression. Genes Dev\u20082002; 16: 2530-43.","DOI":"10.1101\/gad.1024602"},{"key":"2022061620150918200_B6","unstructured":"Freytag SO, Dang CV, Lee WM Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ\u20081990; 1: 339-43."},{"key":"2022061620150918200_B7","doi-asserted-by":"crossref","unstructured":"Freytag SO Enforced expression of the c-myc oncogene inhibits cell differentiation by precluding entry into a distinct predifferentiation state in G0\/G1. Mol Cell Biol\u20081988; 8: 1614-24.","DOI":"10.1128\/MCB.8.4.1614"},{"key":"2022061620150918200_B8","doi-asserted-by":"crossref","unstructured":"Coppola JA, Cole MD Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature\u20081986; 320: 760-3.","DOI":"10.1038\/320760a0"},{"key":"2022061620150918200_B9","doi-asserted-by":"crossref","unstructured":"Miner JH, Wold BJ c-myc inhibition of MyoD and myogenin-initiated myogenic differentiation. Mol Cell Biol\u20081991; 11: 2842-51.","DOI":"10.1128\/mcb.11.5.2842-2851.1991"},{"key":"2022061620150918200_B10","unstructured":"Askew DS, Ashmun RA, Simmons BC, Cleveland JL Constitutive c-myc expression in an IL-3-dependent myeloid cell line suppresses cell cycle arrest and accelerates apoptosis. Oncogene\u20081991; 6: 1915-22."},{"key":"2022061620150918200_B11","doi-asserted-by":"crossref","unstructured":"Evan GI, Wyllie AH, Gilbert CS, et al Induction of apoptosis in fibroblasts by c-myc protein. Cell\u20081992; 69: 119-28.","DOI":"10.1016\/0092-8674(92)90123-T"},{"key":"2022061620150918200_B12","doi-asserted-by":"crossref","unstructured":"Nilsson JA, Cleveland JL Myc pathways provoking cell suicide and cancer. Oncogene\u20082003; 22: 9007-21.","DOI":"10.1038\/sj.onc.1207261"},{"key":"2022061620150918200_B13","unstructured":"Bar-Ner M, Messing LT, Cultraro CM, Birrer MJ, Segal S Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ\u20081992; 3: 183-90."},{"key":"2022061620150918200_B14","doi-asserted-by":"crossref","unstructured":"Stone J, de Lange T, Ramsay G, et al Definition of regions in human c-myc that are involved in transformation and nuclear localization. Mol Cell Biol\u20081987; 7: 1697-709.","DOI":"10.1128\/MCB.7.5.1697"},{"key":"2022061620150918200_B15","doi-asserted-by":"crossref","unstructured":"Eisenman RN Deconstructing myc. Genes Dev\u20082001; 15: 2023-30.","DOI":"10.1101\/gad928101"},{"key":"2022061620150918200_B16","doi-asserted-by":"crossref","unstructured":"Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature\u20081992; 359: 423-6.","DOI":"10.1038\/359423a0"},{"key":"2022061620150918200_B17","doi-asserted-by":"crossref","unstructured":"Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell\u20081993; 72: 233-45.","DOI":"10.1016\/0092-8674(93)90663-B"},{"key":"2022061620150918200_B18","doi-asserted-by":"crossref","unstructured":"Amati B, Littlewood TD, Evan GI, Land H The c-Myc protein induces cell cycle progression and apoptosis through dimerization with Max. EMBO J\u20081993; 12: 5083-7.","DOI":"10.1002\/j.1460-2075.1993.tb06202.x"},{"key":"2022061620150918200_B19","doi-asserted-by":"crossref","unstructured":"Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H Sequence-specific DNA binding by the c-Myc protein. Science (Wash DC)\u20081990; 250: 1149-51.","DOI":"10.1126\/science.2251503"},{"key":"2022061620150918200_B20","doi-asserted-by":"crossref","unstructured":"Nilsson JA, Maclean KH, Keller UB, Pendeville H, Baudino TA, Cleveland JL Mnt loss triggers Myc transcription targets, proliferation, apoptosis, and transformation. Mol Cell Biol\u20082004; 24: 1560-9.","DOI":"10.1128\/MCB.24.4.1560-1569.2004"},{"key":"2022061620150918200_B21","doi-asserted-by":"crossref","unstructured":"Hurlin PJ, Zhou ZQ, Toyo-Oka K, et al Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis. EMBO J\u20082003; 22: 4584-96.","DOI":"10.1093\/emboj\/cdg442"},{"key":"2022061620150918200_B22","doi-asserted-by":"crossref","unstructured":"McArthur GA, Laherty CD, Queva C, et al The Mad protein family links transcriptional repression to cell differentiation. Cold Spring Harb Symp Quant Biol\u20081998; 63: 423-33.","DOI":"10.1101\/sqb.1998.63.423"},{"key":"2022061620150918200_B23","doi-asserted-by":"crossref","unstructured":"Zeller KI, Jegga AG, Aronow BJ, O\u2019Donnell KA, Dang CV An integrated database of genes responsive to the Myc oncogenic transcription factor: identification of direct genomic targets. Genome Biol\u20082003; 4: R69","DOI":"10.1186\/gb-2003-4-10-r69"},{"key":"2022061620150918200_B24","doi-asserted-by":"crossref","unstructured":"Haggerty TJ, Zeller KI, Osthus RC, Wonsey DR, Dang CV A strategy for identifying transcription factor binding sites reveals two classes of genomic c-Myc target sites. Proc Natl Acad Sci USA\u20082003; 100: 5313-8.","DOI":"10.1073\/pnas.0931346100"},{"key":"2022061620150918200_B25","doi-asserted-by":"crossref","unstructured":"Orian A, van Steensel B, Delrow J, et al Genomic binding by the Drosophila Myc, Max, Mad\/Mnt transcription factor network. Genes Dev\u20082003; 17: 1101-14.","DOI":"10.1101\/gad.1066903"},{"key":"2022061620150918200_B26","doi-asserted-by":"crossref","unstructured":"Fernandez PC, Frank SR, Wang L, et al Genomic targets of the human c-Myc protein. Genes Dev\u20082003; 17: 1115-29.","DOI":"10.1101\/gad.1067003"},{"key":"2022061620150918200_B27","unstructured":"Moore JP, Hancock DC, Littlewood TD, Evan GI A sensitive and quantitative enzyme-linked immunosorbence assay for the c-myc and N-myc oncoproteins. Oncogene Res\u20081987; 2: 65-80."},{"key":"2022061620150918200_B28","unstructured":"Waters CM, Littlewood TD, Hancock DC, Moore JP, Evan GI c-myc protein expression in untransformed fibroblasts. Oncogene\u20081991; 6: 797-805."},{"key":"2022061620150918200_B29","unstructured":"Mehmet H, Littlewood TD, Sinnett-Smith J, Moore JP, Evan GI, Rozengurt E Large induction of c-Myc is not essential for the mitogenic response of Swiss 3T3 fibroblasts. Cell Growth Differ\u20081997; 8: 187-93."},{"key":"2022061620150918200_B30","doi-asserted-by":"crossref","unstructured":"Baudino TA, Maclean KH, Brennan J, et al Myc-mediated proliferation and lymphomagenesis, but not apoptosis, are compromised by E2f1 loss. Mol Cell\u20082003; 11: 905-14.","DOI":"10.1016\/S1097-2765(03)00102-3"},{"key":"2022061620150918200_B31","doi-asserted-by":"crossref","unstructured":"Zou X, Ray D, Aziyu A, et al Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf\/p53-independent senescence. Genes Dev\u20082002; 16: 2923-34.","DOI":"10.1101\/gad.1033002"},{"key":"2022061620150918200_B32","doi-asserted-by":"crossref","unstructured":"Lasorella A, Noseda M, Beyna M, Yokota Y, Iavarone A Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins. Nature\u20082000; 407: 592-8.","DOI":"10.1038\/35036504"},{"key":"2022061620150918200_B33","doi-asserted-by":"crossref","unstructured":"Leone G, Sears R, Huang E, et al Myc requires distinct E2F activities to induce S phase and apoptosis. Mol Cell\u20082001; 8: 105-13.","DOI":"10.1016\/S1097-2765(01)00275-1"},{"key":"2022061620150918200_B34","doi-asserted-by":"crossref","unstructured":"Bouchard C, Thieke K, Maier A, et al Direct induction of cyclin D2 by Myc contributes to cell cycle progression and sequestration of p27. EMBO J\u20081999; 18: 5321-33.","DOI":"10.1093\/emboj\/18.19.5321"},{"key":"2022061620150918200_B35","doi-asserted-by":"crossref","unstructured":"Norton JD ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J Cell Sci\u20082000; 113: 3897-905.","DOI":"10.1242\/jcs.113.22.3897"},{"key":"2022061620150918200_B36","doi-asserted-by":"crossref","unstructured":"Morrow MA, Mayer EW, Perez CA, Adlam M, Siu G Overexpression of the Helix-Loop-Helix protein Id2 blocks T cell development at multiple stages. Mol Immunol\u20081999; 36: 491-503.","DOI":"10.1016\/S0161-5890(99)00071-1"},{"key":"2022061620150918200_B37","doi-asserted-by":"crossref","unstructured":"Spits H, Couwenberg F, Bakker AQ, Weijer K, Uittenbogaart CH Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2. J Exp Med\u20082000; 192: 1775-84.","DOI":"10.1084\/jem.192.12.1775"},{"key":"2022061620150918200_B38","doi-asserted-by":"crossref","unstructured":"Yokota Y, Mori S, Narumi O, Kitajima K In vivo function of a differentiation inhibitor, Id2. IUBMB Life\u20082001; 51: 207-14.","DOI":"10.1080\/152165401753311744"},{"key":"2022061620150918200_B39","doi-asserted-by":"crossref","unstructured":"Gonda H, Sugai M, Nambu Y, et al The balance between Pax5 and Id2 activities is the key to AID gene expression. J Exp Med\u20082003; 198: 1427-37.","DOI":"10.1084\/jem.20030802"},{"key":"2022061620150918200_B40","doi-asserted-by":"crossref","unstructured":"Sugai M, Gonda H, Kusunoki T, Katakai T, Yokota Y, Shimizu A Essential role of Id2 in negative regulation of IgE class switching. Nat Immunol\u20082003; 4: 25-30.","DOI":"10.1038\/ni874"},{"key":"2022061620150918200_B41","doi-asserted-by":"crossref","unstructured":"Yokota Y, Mori S Role of Id family proteins in growth control. J Cell Physiol\u20082002; 190: 21-8.","DOI":"10.1002\/jcp.10042"},{"key":"2022061620150918200_B42","doi-asserted-by":"crossref","unstructured":"Lasorella A, Iavarone A, Israel MA Id2 specifically alters regulation of the cell cycle by tumor suppressor proteins. Mol Cell Biol\u20081996; 16: 2570-8.","DOI":"10.1128\/MCB.16.6.2570"},{"key":"2022061620150918200_B43","unstructured":"Lasorella A, Boldrini R, Dominici C, et al Id2 is critical for cellular proliferation and is the oncogenic effector of N-myc in human neuroblastoma. Cancer Res\u20082002; 62: 301-6."},{"key":"2022061620150918200_B44","doi-asserted-by":"crossref","unstructured":"Vandesompele J, Edsjo A, De Preter K, Axelson H, Speleman F, Pahlman S ID2 expression in neuroblastoma does not correlate to MYCN levels and lacks prognostic value. Oncogene\u20082003; 22: 456-60.","DOI":"10.1038\/sj.onc.1206148"},{"key":"2022061620150918200_B45","unstructured":"Wang Q, Hii G, Shusterman S, et al ID2 expression is not associated with MYCN amplification or expression in human neuroblastomas. Cancer Res\u20082003; 63: 1631-5."},{"key":"2022061620150918200_B46","doi-asserted-by":"crossref","unstructured":"Adams JM, Harris AW, Pinkert CA, et al The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature (Lond)\u20081985; 318: 533-8.","DOI":"10.1038\/318533a0"},{"key":"2022061620150918200_B47","doi-asserted-by":"crossref","unstructured":"Yokota Y, Mansouri A, Mori S, et al Development of peripheral lymphoid organs and natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature (Lond)\u20081999; 397: 702-6.","DOI":"10.1038\/17812"},{"key":"2022061620150918200_B48","doi-asserted-by":"crossref","unstructured":"Zindy F, Eischen CM, Randle DH, et al Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev\u20081998; 12: 2424-33.","DOI":"10.1101\/gad.12.15.2424"},{"key":"2022061620150918200_B49","doi-asserted-by":"crossref","unstructured":"Borzillo GV, Sherr CJ Early pre-B-cell transformation induced by the v-fms oncogene in long-term mouse bone marrow cultures. Mol Cell Biol\u20081989; 9: 3973-81.","DOI":"10.1128\/MCB.9.9.3973"},{"key":"2022061620150918200_B50","doi-asserted-by":"crossref","unstructured":"Maclean KH, Keller UB, Rodriguez-Galindo C, Nilsson JA, Cleveland JL c-Myc Augments Gamma Irradiation-Induced Apoptosis by Suppressing Bcl-X(L). Mol Cell Biol\u20082003; 23: 7256-70.","DOI":"10.1128\/MCB.23.20.7256-7270.2003"},{"key":"2022061620150918200_B51","doi-asserted-by":"crossref","unstructured":"Littlewood TD, Hancock DC, Danielian PS, Parker MG, Evan GI A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res\u20081995; 23: 1686-90.","DOI":"10.1093\/nar\/23.10.1686"},{"key":"2022061620150918200_B52","doi-asserted-by":"crossref","unstructured":"Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ Functional and physical interactions of the ARF tumor suppressor with p53 and Mdm2. Proc Natl Acad Sci USA\u20081998; 95: 8292-7.","DOI":"10.1073\/pnas.95.14.8292"},{"key":"2022061620150918200_B53","doi-asserted-by":"crossref","unstructured":"Murphy DJ, Swigart LB, Israel MA, Evan GI Id2 is dispensable for Myc-induced epidermal neoplasia. Mol Cell Biol\u20082004; 24: 2083-90.","DOI":"10.1128\/MCB.24.5.2083-2090.2004"},{"key":"2022061620150918200_B54","doi-asserted-by":"crossref","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci USA\u20081982; 79: 7824-7.","DOI":"10.1073\/pnas.79.24.7824"},{"key":"2022061620150918200_B55","doi-asserted-by":"crossref","unstructured":"Bello-Fernandez C, Packham G, Cleveland JL The ornithine decarboxylase gene is a transcriptional target of c-Myc. Proc Natl Acad Sci USA\u20081993; 90: 7804-8.","DOI":"10.1073\/pnas.90.16.7804"},{"key":"2022061620150918200_B56","doi-asserted-by":"crossref","unstructured":"Leone G, DeGregori J, Sears R, Jakoi L, Nevins JR Myc and Ras collaborate in inducing accumulation of active cyclin E\/Cdk2 and E2F. Nature (Lond)\u20081997; 387: 422-6.","DOI":"10.1038\/387422a0"},{"key":"2022061620150918200_B57","doi-asserted-by":"crossref","unstructured":"Bello-Fernandez C, Cleveland JL c-myc transactivates the ornithine decarboxylase gene. Curr Top Microbiol Immunol\u20081992; 182: 445-52.","DOI":"10.1007\/978-3-642-77633-5_56"},{"key":"2022061620150918200_B58","doi-asserted-by":"crossref","unstructured":"Miltenberger RJ, Sukow KA, Farnham PJ An E-box-mediated increase in cad transcription at the G1\/S-phase boundary is suppressed by inhibitory c-Myc mutants. Mol Cell Biol\u20081995; 15: 2527-35.","DOI":"10.1128\/MCB.15.5.2527"},{"key":"2022061620150918200_B59","doi-asserted-by":"crossref","unstructured":"Futterer A, Mink K, Luz A, Kosco-Vilbois MH, Pfeffer K The lymphotoxin beta receptor controls organogenesis and affinity maturation in peripheral lymphoid tissues. Immunity\u20081998; 9: 59-70.","DOI":"10.1016\/S1074-7613(00)80588-9"},{"key":"2022061620150918200_B60","doi-asserted-by":"crossref","unstructured":"Malynn BA, de Alboran IM, O\u2019Hagan RC, et al N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Genes Dev\u20082000; 14: 1390-9.","DOI":"10.1101\/gad.14.11.1390"},{"key":"2022061620150918200_B61","doi-asserted-by":"crossref","unstructured":"Lewis BC, Shim H, Li Q, et al Identification of putative c-Myc-responsive genes: characterization of rcl, a novel growth-related gene. Mol Cell Biol\u20081997; 17: 4967-78.","DOI":"10.1128\/MCB.17.9.4967"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/20\/7296\/2520261\/zch02004007296.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/64\/20\/7296\/2520261\/zch02004007296.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T21:16:55Z","timestamp":1655414215000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/64\/20\/7296\/511935\/Id2-Is-Dispensable-for-Myc-Induced-Lymphomagenesis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,10,15]]},"references-count":61,"journal-issue":{"issue":"20","published-online":{"date-parts":[[2004,10,15]]},"published-print":{"date-parts":[[2004,10,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-04-2133","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,10,15]]}}}